Advanced search
Publication Cover
Journal of Blood Medicine Volume 13, 2022 - Issue
Submit an article Journal homepage
158
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Endocrine Complications and the Effect of Compliance with Chelation Therapy in Patients with Beta Thalassemia Major in Eastern Province of Saudi Arabia

Fatema HabbashDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Wegdan Al-BatiDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Howra Al-HashimDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Maryam AldossariDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, BahrainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4307-4072
ORCID Icon,
Ahmed AlaliDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Khalid AlalyaniDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Zainab Al-EbrahimDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Nouf HamedDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Samma EraqeDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Ziyad BinayfanDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
,
Azzam Al MarriDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
&
Thamer AljaberDepartment of Family and Community Medicine, College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain
 show all
Pages 763-774 | Received 08 Sep 2022, Accepted 18 Nov 2022, Published online: 07 Dec 2022

References

  • Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1). doi:10.1186/1750-1172-5-11
  • Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010;12(2):61–76. doi:10.1097/GIM.0b013e3181cd68ed
  • Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol. 2010;3(1):103–117. doi:10.1586/ehm.09.74
  • Alsaeed ES, Farhat GN, Assiri AM, et al. Distribution of hemoglobinopathy disorders in Saudi Arabia based on data from the premarital screening and genetic counseling program, 2011–2015. J Epidemiol Glob Health. 2018;7(1). doi:10.1016/j.jegh.2017.12.001
  • Ahmad AS. Prevalence of β -thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia. Ann Saudi Med. 2006;26(1):14–16. doi:10.5144/0256-4947.2006.14
  • Mohamed SY. Thalassemia major: transplantation or transfusion and chelation. Hematol Oncol Stem Cell Ther. 2017;10(4):290–298. doi:10.1016/j.hemonc.2017.05.022
  • Piga A, Roggero S, Marletto F, Sacchetti L, Longo F. Combined use of oral chelators and desferrioxamine in thalassemia. Hematology. 2005;10(Suppl 1):89–91. doi:10.1080/10245330512331389737
  • Belmont A, Kwiatkowski JL. Deferiprone for the treatment of transfusional iron overload in thalassemia. Expert Rev Hematol. 2017;10(6):493–503. doi:10.1080/17474086.2017.1318052
  • Olivieri NF, Brittenham GM, McLaren CE, et al. Long-term safety and effectiveness of iron-chelation therapy with deferiprone for thalassemia major. N Engl J Med. 1998;339(7):417–423. doi:10.1056/nejm199808133390701
  • Goyal JP, Hapani PT, Gagiya H. Prevalence of human immunodeficiency virus and hepatitis B among multi-transfused thalassemia children. J Appl Hematol. 2015;6(2):70–73. doi:10.4103/1658-5127.160204
  • Habeb AM, Al-Hawsawi ZM, Morsy MM, et al. Endocrinopathies in beta-thalassemia major. Prevalence, risk factors, and age at diagnosis in Northwest Saudi Arabia. Saudi Med J. 2013;34(1):67–73. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=23299162&site=eds-live.
  • Yousefian S, Aliabad GM, Saleh R, Khedmati M. Association of Body mass index and serum ferritin level in pediatrics with Beta-thalassemia major disease. Iran J Pediatr Hematol Oncol. 2022;12(1):34–40. doi:10.18502/ijpho.v12i1.8359
  • Arab-Zozani M, Kheyrandish S, Rastgar A, Miri-Moghaddam E. A systematic review and meta-analysis of stature growth complications in β-thalassemia major patients. Ann Glob Health. 2021;87(1):1–17. doi:10.5334/aogh.3184
  • Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3:4–6. doi:10.1186/1472-6823-3-4
  • Casale M, Citarella S, Filosa A, et al. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. Am J Hematol. 2014;89(12):1102–1106. doi:10.1002/ajh.23844
  • Farzad N, Akbar A, Naser A, et al. A cross-sectional study of metabolic and endocrine complications in beta-thalassemia major. Ann Saudi Med. 2008;28(5):361–366. doi:10.5144/0256-4947.2008.361
  • Ward A, Caro JJ, Green TC, et al. An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clin Pharmacol. 2002;2:3. doi:10.1186/1472-6904-2-3

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.